Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway
- 25 May 1999
- journal article
- Published by Springer Nature in Oncogene
- Vol. 18 (21) , 3290-3302
- https://doi.org/10.1038/sj.onc.1202681
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 60 references indexed in Scilit:
- Book ReviewsDevelopment Policy Review, 1998
- Role for Cyclin A-dependent Kinase in DNA Replication in Human S Phase Cell ExtractsPublished by Elsevier ,1996
- Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damageCurrent Biology, 1996
- Inhibition of Nucleotide Excision Repair by the Cyclin-dependent Kinase Inhibitor p21Published by Elsevier ,1995
- A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigenCurrent Biology, 1995
- Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision—repairCurrent Biology, 1994
- The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNANature, 1994
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Nuclear targeting sequences — a consensus?Trends in Biochemical Sciences, 1991